Cargando…
PARP-1 Modulation of mTOR Signaling in Response to a DNA Alkylating Agent
Poly(ADP-ribose) polymerase-1 (PARP-1) is widely involved in cell death responses. Depending on the degree of injury and on cell type, PARP activation may lead to autophagy, apoptosis or necrosis. In HEK293 cells exposed to the alkylating agent N-methyl-N’-nitro-N’-nitrosoguanine (MNNG), we show tha...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480502/ https://www.ncbi.nlm.nih.gov/pubmed/23110147 http://dx.doi.org/10.1371/journal.pone.0047978 |
_version_ | 1782247578184712192 |
---|---|
author | Éthier, Chantal Tardif, Maxime Arul, Laura Poirier, Guy G. |
author_facet | Éthier, Chantal Tardif, Maxime Arul, Laura Poirier, Guy G. |
author_sort | Éthier, Chantal |
collection | PubMed |
description | Poly(ADP-ribose) polymerase-1 (PARP-1) is widely involved in cell death responses. Depending on the degree of injury and on cell type, PARP activation may lead to autophagy, apoptosis or necrosis. In HEK293 cells exposed to the alkylating agent N-methyl-N’-nitro-N’-nitrosoguanine (MNNG), we show that PARP-1 activation triggers a necrotic cell death response. The massive poly(ADP-ribose) (PAR) synthesis following PARP-1 activation leads to the modulation of mTORC1 pathway. Shortly after MNNG exposure, NAD(+) and ATP levels decrease, while AMP levels drastically increase. We characterized at the molecular level the consequences of these altered nucleotide levels. First, AMP-activated protein kinase (AMPK) is activated and the mTORC1 pathway is inhibited by the phosphorylation of Raptor, in an attempt to preserve cellular energy. Phosphorylation of the mTORC1 target S6 is decreased as well as the phosphorylation of the mTORC2 component Rictor on Thr1135. Finally, Akt phosphorylation on Ser473 is lost and then, cell death by necrosis occurs. Inhibition of PARP-1 with the potent PARP inhibitor AG14361 prevents all of these events. Moreover, the antioxidant N-acetyl-L-cysteine (NAC) can also abrogate all the signaling events caused by MNNG exposure suggesting that reactive oxygen species (ROS) production is involved in PARP-1 activation and modulation of mTOR signaling. In this study, we show that PARP-1 activation and PAR synthesis affect the energetic status of cells, inhibit the mTORC1 signaling pathway and possibly modulate the mTORC2 complex affecting cell fate. These results provide new evidence that cell death by necrosis is orchestrated by the balance between several signaling pathways, and that PARP-1 and PAR take part in these events. |
format | Online Article Text |
id | pubmed-3480502 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-34805022012-10-29 PARP-1 Modulation of mTOR Signaling in Response to a DNA Alkylating Agent Éthier, Chantal Tardif, Maxime Arul, Laura Poirier, Guy G. PLoS One Research Article Poly(ADP-ribose) polymerase-1 (PARP-1) is widely involved in cell death responses. Depending on the degree of injury and on cell type, PARP activation may lead to autophagy, apoptosis or necrosis. In HEK293 cells exposed to the alkylating agent N-methyl-N’-nitro-N’-nitrosoguanine (MNNG), we show that PARP-1 activation triggers a necrotic cell death response. The massive poly(ADP-ribose) (PAR) synthesis following PARP-1 activation leads to the modulation of mTORC1 pathway. Shortly after MNNG exposure, NAD(+) and ATP levels decrease, while AMP levels drastically increase. We characterized at the molecular level the consequences of these altered nucleotide levels. First, AMP-activated protein kinase (AMPK) is activated and the mTORC1 pathway is inhibited by the phosphorylation of Raptor, in an attempt to preserve cellular energy. Phosphorylation of the mTORC1 target S6 is decreased as well as the phosphorylation of the mTORC2 component Rictor on Thr1135. Finally, Akt phosphorylation on Ser473 is lost and then, cell death by necrosis occurs. Inhibition of PARP-1 with the potent PARP inhibitor AG14361 prevents all of these events. Moreover, the antioxidant N-acetyl-L-cysteine (NAC) can also abrogate all the signaling events caused by MNNG exposure suggesting that reactive oxygen species (ROS) production is involved in PARP-1 activation and modulation of mTOR signaling. In this study, we show that PARP-1 activation and PAR synthesis affect the energetic status of cells, inhibit the mTORC1 signaling pathway and possibly modulate the mTORC2 complex affecting cell fate. These results provide new evidence that cell death by necrosis is orchestrated by the balance between several signaling pathways, and that PARP-1 and PAR take part in these events. Public Library of Science 2012-10-24 /pmc/articles/PMC3480502/ /pubmed/23110147 http://dx.doi.org/10.1371/journal.pone.0047978 Text en © 2012 Éthier et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Éthier, Chantal Tardif, Maxime Arul, Laura Poirier, Guy G. PARP-1 Modulation of mTOR Signaling in Response to a DNA Alkylating Agent |
title | PARP-1 Modulation of mTOR Signaling in Response to a DNA Alkylating Agent |
title_full | PARP-1 Modulation of mTOR Signaling in Response to a DNA Alkylating Agent |
title_fullStr | PARP-1 Modulation of mTOR Signaling in Response to a DNA Alkylating Agent |
title_full_unstemmed | PARP-1 Modulation of mTOR Signaling in Response to a DNA Alkylating Agent |
title_short | PARP-1 Modulation of mTOR Signaling in Response to a DNA Alkylating Agent |
title_sort | parp-1 modulation of mtor signaling in response to a dna alkylating agent |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480502/ https://www.ncbi.nlm.nih.gov/pubmed/23110147 http://dx.doi.org/10.1371/journal.pone.0047978 |
work_keys_str_mv | AT ethierchantal parp1modulationofmtorsignalinginresponsetoadnaalkylatingagent AT tardifmaxime parp1modulationofmtorsignalinginresponsetoadnaalkylatingagent AT arullaura parp1modulationofmtorsignalinginresponsetoadnaalkylatingagent AT poirierguyg parp1modulationofmtorsignalinginresponsetoadnaalkylatingagent |